ANALYST RECOMMENDATIONS : Eli Lilly, KLA, Kellogg, Epam Systems, BeiGene...

Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.

 

• Atlas Air Worldwide Holdings: Susquehanna Financial downgrades to neutral from positive. PT up 2.8% to $102.50.
• Ball:  Atlantic Equities LLP cut the recommendation to neutral from overweight. PT set to $58.
• BeiGene: ICBC Research reinstated coverage with a recommendation of buy. PT up 36% to $260.10.
• Bio-Techne: Stifel cut the target cut the target to $500 from $560. Maintains buy rating.
• Celanese: Piper Sandler cut the target to $120 from $145. Maintains underweight rating.
• ConvaTec: Bank of America downgrades to neutral from buy.
• Dunelm Group: Stifel initiated coverage with a recommendation of sell. PT down 18% to 700 pence.
• Eli Lilly:  Cantor Fitzgerald maintains overweight rating. PT up 18% to $360.
• Epam Systems: Cowen raised the target to $440 from $400. Maintains outperform rating.
• Hikma Pharmaceuticals: Barclays downgrades to equal-weight from overweight. PT up 6% to 1.750 pence.
• Kellogg: Piper Sandler raised the recommendation to neutral from underweight. PT set to $74.
• KLA: Cowen cut the target to $55 from $68. Maintains market perform rating.
• Paramount Global: J.P. Morgan cut the recommendation  to underweight from neutral. PT set to $25.
• Next: Goldman Sachs reduces to neutral from buy. PT up 13% to 7.600 pence.
• Unite Group: Stifel cut the recommendation to hold from buy. PT set to 1.170 pence.
• Yeti Holdings: Piper Sandler maintains overweight rating. PT down to $76.